Invesco Ltd. Albireo Pharma, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$18.54 - $37.29 $125,701 - $252,826	-6,780 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$23.94 - $33.74 $162,313 - $228,757	6,780 New	6,780 $203,000
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $151,127 - $223,160	-7,132 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.36 - $35.98 $35,677 - $46,917	1,304 Added 22.37%	7,132 $223,000
Q2 2021 Aug 17, 2021	BUY	$28.9 - $36.87 $168,429 - $214,878	5,828 New	5,828 $205,000

Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $789,757 - $1.06 Million	-25,024 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $580,306 - $1.04 Million	25,024 New	25,024 $835,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.